Related Experiment Video
Updated: May 10, 2025

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution following Multicancer Early
Catherine R Marinac1, Charles H McDonnell2, Lincoln D Nadauld3
1Dana-Farber Cancer Institute, Boston, Massachusetts.
Multi-cancer early detection (MCED) tests guide cancer diagnosis. Cancer signal origin (CSO) prediction-directed evaluations resolved most cases, though some needed further testing for persistent suspicion.
Area of Science:
- Oncology
- Diagnostic Medicine
- Biotechnology
Background:
- Blood-based multi-cancer early detection (MCED) tests are emerging tools for cancer screening.
- Evaluating cancer signal detected (CSD) results and predicting cancer signal origin (CSO) are critical steps in the diagnostic pathway.
Purpose of the Study:
- To assess the diagnostic utility of CSO prediction-guided evaluations for MCED test results.
- To determine if participants with risk factors and negative initial evaluations were diagnosed with cancer during follow-up.
- To evaluate the role of whole-body imaging (WBI) and compare diagnostic journeys for true- and false-positive MCED results.
Main Methods:
- Analysis of diagnostic journeys for 39 participants with CSD on initial and refined MCED tests in the PATHFINDER study.
- Evaluation of CSO prediction-directed diagnostic workups and subsequent diagnostic resolution.
- Assessment of WBI utility and comparison of diagnostic procedures (imaging, surgical, non-surgical) between true- and false-positive results.
Main Results:
- 82% of participants achieved diagnostic resolution after initial evaluation, with 78% specifically using CSO prediction-directed workups.
- 18% required additional evaluation for persistent suspicion, all achieving resolution (some with cancer, some without).
- WBI contributed to resolution in 49% of CSD cases; 90% of cases had imaging, with true-positives more likely to undergo procedures than false-positives (81% vs 38.9%).
Conclusions:
- CSO prediction-directed evaluations effectively facilitated diagnostic resolution for the majority of participants with MCED-detected signals.
- Persistent clinical suspicion in initially negative evaluations necessitated further testing, ultimately leading to resolution.
- The study highlights the importance of guided diagnostic pathways and the varied utility of imaging and procedures in confirming MCED findings.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019